5-methylcytosine and Local Neoplasm Recurrence
5-methylcytosine has been researched along with Local Neoplasm Recurrence in 8 studies
Research
Studies (8)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 5 (62.50) | 2.80 |
Authors
Authors | Studies |
---|---|
Arora, A; Bisht, D; Sachan, M | 1 |
Alves, APNN; Bezerra, MJB; Furtado, CLM; Hirth, CG; Lima, MVA; Moraes Filho, MO; Moura, AAA; Paula, DS; Pessoa, CDÓ; Pinheiro, DP; Santos, RDS; Silva-Fernandes, IJL | 1 |
Barciszewska, AM; Barciszewski, J; Belter, A | 1 |
Cai, Z; Chen, G; Chen, H; Dong, X; He, Y; Hu, X; Liu, J; Liu, X; Wang, Y; Xia, L; Xie, D; Zhang, J; Zhong, S; Zhou, Y | 1 |
Lin, B; Ren, G; Wang, L | 1 |
Bechara, FG; Gambichler, T; Hessam, S; Rüddel, I; Schmitz, L; Stockfleth, E | 1 |
Becker, JC; Dreibigacker, M; Gambichler, T; Rüddel, I; Schmitt, K; Stockfleth, E | 1 |
Dai, Z; Ding, ZB; Fan, J; Jin, L; Liu, WR; Peng, YF; Qiu, SJ; Shen, YH; Shi, YH; Tian, MX; Yang, LX; Zhou, J | 1 |
Reviews
1 review(s) available for 5-methylcytosine and Local Neoplasm Recurrence
Article | Year |
---|---|
Role of DNA De-methylation intermediate '5-hydroxymethylcytosine' in ovarian cancer management: A comprehensive review.
Topics: 5-Methylcytosine; Carcinoma, Ovarian Epithelial; DNA; DNA Methylation; Epigenesis, Genetic; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms | 2022 |
Other Studies
7 other study(ies) available for 5-methylcytosine and Local Neoplasm Recurrence
Article | Year |
---|---|
HPV infection and 5mC/5hmC epigenetic markers in penile squamous cell carcinoma: new insights into prognostics.
Topics: 5-Methylcytosine; Alphapapillomavirus; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; DNA, Viral; Epigenesis, Genetic; Humans; Male; Neoplasm Recurrence, Local; Papillomaviridae; Papillomavirus Infections; Penile Neoplasms; Prognosis | 2022 |
Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions.
Topics: 5-Methylcytosine; Brain Neoplasms; Cell Line, Tumor; DNA Methylation; DNA Modification Methylases; Drug Resistance, Neoplasm; Epigenesis, Genetic; Epigenomics; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Temozolomide | 2020 |
Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
Topics: 5-Methylcytosine; Biomarkers; Carcinoma, Hepatocellular; Cell-Free Nucleic Acids; Humans; Liquid Biopsy; Liver Neoplasms; Neoplasm Recurrence, Local; Prognosis | 2021 |
Expression of 5-methylcytosine regulators is highly associated with the clinical phenotypes of prostate cancer and DNMTs expression predicts biochemical recurrence.
Topics: 5-Methylcytosine; Datasets as Topic; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kallikreins; Male; Models, Genetic; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment; ROC Curve; Tumor Microenvironment | 2021 |
Altered epigenetic pathways and cell cycle dysregulation in healthy appearing skin of patients with koebnerized squamous cell carcinomas following skin surgery.
Topics: 5-Methylcytosine; Azathioprine; Carcinoma, Squamous Cell; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p16; Deoxycytidine; Dimethyl Fumarate; Dioxygenases; DNA-Binding Proteins; Epigenesis, Genetic; ErbB Receptors; Female; Humans; Immunosuppressive Agents; Isocitrate Dehydrogenase; Ki-67 Antigen; Male; Middle Aged; Multiple Sclerosis; Neoplasm Recurrence, Local; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Skin; Skin Neoplasms; Skin Physiological Phenomena; Tumor Suppressor Protein p53 | 2018 |
Decreased 5-hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease-specific death.
Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Merkel Cell; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Follow-Up Studies; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Male; Merkel cell polyomavirus; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Proto-Oncogene Proteins; Sex Factors; Skin; Skin Neoplasms; Viral Load | 2019 |
High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma.
Topics: 5-Methylcytosine; Carcinoma, Hepatocellular; Cytosine; DNA Methylation; Female; Hepatectomy; Humans; Isocitrate Dehydrogenase; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Retrospective Studies; Treatment Outcome | 2014 |